Zentek (ZTEK) - EV/EBITDA Multiple

Zentek Corp - graphic logo of issuer ZTEK

Under the leadership of Greg Fenton, Zentek Ltd. (ZTEK) is bringing unique graphene developments into commercial circulation, creating a protected B2B environment leveraging its own patents. This chart of trades on GURU.Markets serves as a business valuation indicator, where EV/EBITDA stands at 0.00. Zentek Ltd. (ZTEK) relies on diversified revenue streams, supplying innovative nanomaterials for diagnostic systems and the industrial sector.

ZTEK Zentek Limited: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 09/12/2026

Analytical breakdowns for Zentek Ltd (ZTEK)

- stock price and consensus target price:
Stock Quotes Zentek Ltd.|ZTEK - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Zentek Limited|ZTEK - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Zentek|ZTEK - Accounting Capitalization|Market Value to Book Value Ratio zentek.com|ZTEK - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio Zentek Ltd.|ZTEK - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Zentek Limited|ZTEK - Aggregate Debt Obligations|Debt to Book Value Zentek|ZTEK - Company Long-Term Debts|Company Short-Term Debt Zentek|Quick Ratio zentek.com
- business earnings and investment ratios data:
ZTEK - Company Net Income|Expected Profit Zentek Ltd.|ZTEK - Price to Earnings Multiple|Projected Price to Earnings Zentek Ltd.|ZTEK - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zentek Limited|ZTEK - Operating income before deduction of amortization|Net earnings per share for the last 12 months Zentek|ZTEK - Earnings per one share for the last 12 months|Quarterly EPS earnings growth zentek.com|ZTEK - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Zentek Ltd.
- sales and revenue indicators:
ZTEK - Company Sales Volume|Company Future Sales Volume Zentek Limited|ZTEK - Market Cap to Sales Volume|Forward P/S Multiple Zentek Corp
Summary company analysis:Zentek Corp (ZTEK)
Manufactured products of Zentek

This indicator compares the aggregate value of assets and liabilities against operating income, allowing for an assessment of the business's real value excluding tax and debt influence. An EV/EBITDA multiple analysis reveals that the asset is overbought, which is critical for Zentek Ltd. (ZTEK), as its investments in nanotechnology for environmental remediation and ESG filters require significant capital expenditures and precise control over capital efficiency.

Competitors of Zentek Ltd.

Intuitive Surgical - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio danaher.com (DHR)|BDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|STE (STERIS PLC) - Enterprise Value to Operating Income Before Depreciation|West Pharma Corp (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BAX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization masimo.com|Stevanato Group (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Teleflex (TFX)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista Holdings Corp NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure Inc (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio STAAR Surgical|NAGE (niagenbioscience.com) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Corp ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics (ANGO)|Cerus - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (Monogram Technologies Inc.)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio infusystem.com INFU|UTMD (Utah Med) - Enterprise Value to EBITDA Ratio|KORU Medical Systems Inc. (KRMD) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio NYXH|Microbot Medical (MBOT) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization pro-dex.com (PDEX)|EV/EBITDA Multiple Elutia Inc. (ELUT)|EV/EBITDA Multiple MLSS (Milestone Scientific Inc)|Enterprise Value to EBITDA Multiple NEXGEL, Inc.|Retractable Technologies, Inc. - EV/EBITDA Multiple|HBIO - EV/EBITDA Multiple|FEMY (femasys.com) - Enterprise Value to EBITDA Ratio|Meihua Medical (MHUA) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio POAI|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|Enterprise Value to Operating Income Before Depreciation Ratio NURO